**Core Concept:** Teratogens are substances or conditions that can cause birth defects or developmental abnormalities. Imatinib is an example of a tyrosine kinase inhibitor used to treat certain types of cancer.

**Why the Correct Answer is Right:** Imatinib is a potent inhibitor of the BCR-ABL tyrosine kinase enzyme, which is overactive in chronic myeloid leukemia (CML) and some cases of acute lymphoblastic leukemia (ALL). By inhibiting this enzyme, Imatinib helps prevent cell division and growth of cancerous cells, making it a crucial drug in the treatment of CML and some cases of ALL.

**Why Each Wrong Option is Incorrect:**

A. Chronic myeloid leukemia (CML) is a correct answer, but it is not a teratogen. Imatinib is used to treat CML and not cause any birth defects.

B. Acute lymphoblastic leukemia (ALL) is also a correct answer, but it is a type of cancer that can be treated with Imatinib, not a teratogen.

C. This option is incorrect, as it refers to another drug (Phenytoin) unrelated to Imatinib.

D. This option is incorrect, as it refers to a condition (tuberculosis) unrelated to Imatinib.

**Clinical Pearl:** Imatinib is an essential medication in the treatment of certain types of leukemia, but it is not a teratogen. Practitioners should counsel patients taking Imatinib about the potential risks of medication-related birth defects, while emphasizing the benefit of treating life-threatening cancers like CML and ALL.